DNA binding modes of leukemia oncoproteins.
作者信息
Minucci Saverio
机构信息
EUROPEAN INSTITUTE OF ONCOLOGY; UNIVERSITY OF MILAN.
出版信息
Blood. 2016 Jan 14;127(2):177-8. doi: 10.1182/blood-2015-11-681080.
PMID:26769772
Abstract
摘要
相似文献
1
DNA binding modes of leukemia oncoproteins.白血病癌蛋白的DNA结合模式。
Blood. 2016 Jan 14;127(2):177-8. doi: 10.1182/blood-2015-11-681080.
2
AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia.AML1/ETO与POU4F1协同作用驱动t(8;21)急性髓系白血病典型的B淋巴细胞基因表达。
Leukemia. 2012 May;26(5):1131-5. doi: 10.1038/leu.2011.316. Epub 2011 Nov 8.
3
Aleukaemic acute myeloid leukaemia with t(8;21)(q22;q22).伴有t(8;21)(q22;q22)的非白血病性急性髓系白血病
Br J Haematol. 2009 Aug;146(4):345. doi: 10.1111/j.1365-2141.2009.07580.x. Epub 2009 Feb 13.
4
Acute myeloid leukemia with a novel t(8;21) variant: paracentric inversion-associated ins(21;8).伴有新型t(8;21)变异的急性髓系白血病：与臂间倒位相关的插入(21;8)
Leuk Lymphoma. 2014 Feb;55(2):441-3. doi: 10.3109/10428194.2013.801469. Epub 2013 Jun 14.
5
NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.在AML1-ETO阳性髓系白血病细胞中，ETO的NHR4结构域突变可能非常罕见。
Leukemia. 2010 Apr;24(4):860-1. doi: 10.1038/leu.2009.291. Epub 2010 Jan 21.
6
JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
Leukemia. 2007 Jan;21(1):183-4. doi: 10.1038/sj.leu.2404465. Epub 2006 Nov 9.
7
A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia.急性髓系白血病中AML1-ETO的一个新外显子对t(8;21)的克隆形成潜力产生负面影响。
Leukemia. 2010 Apr;24(4):891-4. doi: 10.1038/leu.2009.288. Epub 2010 Jan 28.
8
Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.一例急性髓性白血病中伴有RUNX1/CBFA2T1（AML1/ETO）转录本的变异易位t(2;21;8)(q36;q22;q22) 。
Cancer Genet Cytogenet. 2005 May;159(1):96-7. doi: 10.1016/j.cancergencyto.2004.10.003.
9
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.在使用伊马替尼治疗慢性粒细胞白血病期间，费城染色体阴性克隆进化后出现伴t(8;21)(q22;q22)和RUNX1-RUNX1T1融合的急性髓系白血病。
Cancer Genet Cytogenet. 2009 Feb;189(1):63-7. doi: 10.1016/j.cancergencyto.2008.09.016.
10
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.AML1及AML1-ETO融合蛋白在t(8;21)急性髓系白血病发病机制中的作用
Oncogene. 2001 Sep 10;20(40):5660-79. doi: 10.1038/sj.onc.1204593.
引用本文的文献
1
Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML.组蛋白去乙酰化酶 3 优先与转录因子 RUNX1 结合并协同作用，以抑制 t(8;21) AML 中 AML1-ETO 依赖性转录。
J Biol Chem. 2020 Mar 27;295(13):4212-4223. doi: 10.1074/jbc.RA119.010707. Epub 2020 Feb 18.
Zotero 插件